Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Op Bio Factory Co. Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This 1 pending office action is assigned to 1 distinct examiner. The matter is located within 1 distinct art unit. This profile shows a focused pending portfolio, with only 1 application currently undergoing active prosecution in this technical field. The concentration of the workload in 1 distinct art unit suggests a specific technical classification for the company's current intellectual property efforts.
The busiest examiner is WILLIAMS, EMMALEE RAE, who is responsible for 1 pending office action. This examiner is the only individual currently managing a pending matter for the company. With 1 distinct examiner and 1 distinct art unit, the company's prosecution is entirely concentrated. This means that the immediate results in the biotechnology and pharmaceuticals sector depend on the review of this examiner. Practitioners should focus their efforts on addressing the specific requirements and feedback of WILLIAMS, EMMALEE RAE to advance the application through the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILLIAMS, EMMALEE RAE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18763414 | MICROALGAE-CONTAINING PRODUCT AND PRODUCTION METHOD THEREFOR | WILLIAMS, EMMALEE RAE | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18763414 | MICROALGAE-CONTAINING PRODUCT AND PRODUCTION METHOD THEREFOR | WILLIAMS, EMMALEE RAE | 1653 | §102§112 | Non-Final OA | — | Pending | Jul 03, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOp Bio Factory Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Emmalee Rae Williams has the most, with 1 of Op Bio Factory Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
